Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.2K
Overview
44.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the Interplay Between Prior Weight and Variance of the Robustification Component in Robust Mixture Prior Bayesian Dynamic Borrowing Approach.

Statistics in medicine·2026
Same author

New, Shorter Small-Sample Intervals for Vaccine Efficacy.

Pharmaceutical statistics·2026
Same author

Dual-Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time-to-Event Group Sequential Trials.

Statistics in medicine·2026
Same author

Estimating the Optimal Time to Perform a Positron Emission Tomography With Prostate-Specific Membrane Antigen in Prostatectomized Patients, Based on Data From Clinical Practice.

Biometrical journal. Biometrische Zeitschrift·2025
Same author

Incorporation of healthy volunteers data on receptor occupancy into a phase II proof-of-concept trial using a Bayesian dynamic borrowing design.

Biometrical journal. Biometrische Zeitschrift·2023
Same author

Predictive probability of success using surrogate endpoints.

Statistics in medicine·2018

Related Experiment Video

Updated: Jun 13, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.6K

On Some Modeling Issues in Estimating Vaccine Efficacy.

Mauro Gasparini1

  • 1Department of Mathematical Sciences "G.L. Lagrange", Politecnico di Torino, Torino, Italy.

Pharmaceutical Statistics
|September 10, 2024
PubMed
Summary
This summary is machine-generated.

This analysis re-examines the Pfizer-BioNTech vaccine trial statistics, offering alternative viewpoints and clarifying theoretical aspects of Bayesian statistics in clinical applications.

Keywords:
BioNTtechCovid‐19Pfizerincidence rate

More Related Videos

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.2K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

12.5K

Related Experiment Videos

Last Updated: Jun 13, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

10.6K
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
06:26

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis

Published on: July 28, 2023

2.2K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

12.5K

Area of Science:

  • Biostatistics
  • Vaccinology
  • Clinical Trials

Background:

  • Recent statistical analysis of the Pfizer-BioNTech vaccine trial by Prof. Senn has been published.
  • The analysis has generated discussion regarding statistical methodologies and interpretations.

Purpose of the Study:

  • To critically re-evaluate the statistical analysis of the Pfizer-BioNTech vaccine trial.
  • To present alternative statistical opinions and theoretical clarifications.
  • To focus on the clinical applications of Bayesian statistics in vaccine trials.

Main Methods:

  • Revisiting the statistical methods employed in the original analysis.
  • Applying Bayesian statistical principles for re-interpretation.
  • Theoretical discussion of statistical concepts relevant to vaccine efficacy.

Main Results:

  • Identified areas for alternative statistical interpretation of the trial data.
  • Demonstrated the utility of Bayesian approaches for clinical vaccine trial analysis.
  • Provided theoretical clarifications on statistical concepts.

Conclusions:

  • The re-evaluation offers a different perspective on the Pfizer-BioNTech vaccine trial's statistical findings.
  • Bayesian statistics can provide valuable insights into clinical applications within vaccine trials.
  • Further discussion on statistical methodologies in vaccine research is warranted.